Skip to main content
SpringerLink
Log in

Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults

  • Invited Manuscript
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Neuro-oncology Disease Site Group et al (2004) Radiotherapy for newly diagnosed malignant glioma in adults. Practice Guideline Report 9-3

  2. Shapiro WR, Young DF (1976) Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch Neurol 33(7):494–550

    PubMed  CAS  Google Scholar 

  3. Walker MD et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49(3):333–343

    PubMed  CAS  Google Scholar 

  4. Walker MD et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Eng J Med 303(23):1323–1329

    CAS  Google Scholar 

  5. Kristiansen K et al (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649–652

    Article  PubMed  CAS  Google Scholar 

  6. Sandberg-Wollheim M et al (1991) A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 68(1):22–29

    Article  PubMed  CAS  Google Scholar 

  7. Laperriere N, Zuraw L, Cairncross G (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64(3):259–273

    Article  PubMed  Google Scholar 

  8. Andersen AP (1978) Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 17(6):475–484

    PubMed  CAS  Google Scholar 

  9. Bleehen NM, Stenning SP (1991) A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 64(4):769–774

    PubMed  CAS  Google Scholar 

  10. Nelson DF et al (1993) Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma–possible advantage observed at 72.0 Gy in 1.2 Gy B·I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int J Radiat Oncol Biol Phys 25(2):193–207

    PubMed  CAS  Google Scholar 

  11. Chang CH et al (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52(6):997–1007

    Article  PubMed  CAS  Google Scholar 

  12. Nelson DF et al (1988) Combined modality approach to treatment of malignant gliomas—reevaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 1988(6):279–284

    Google Scholar 

  13. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725–1731

    PubMed  CAS  Google Scholar 

  14. Lee S et al (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43:79–88

    PubMed  CAS  Google Scholar 

  15. Massey V, Wallner K (1990) Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 18:395–398

    PubMed  CAS  Google Scholar 

  16. Wallner K et al (1989) Patterns of failure following treatment for glioblastoma and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405–1409

    PubMed  CAS  Google Scholar 

  17. Shapiro WR et al (1989) Randomized trial of three chemotherapy regimens, two radiotherapy regimens, two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71(1):1–9

    PubMed  CAS  Google Scholar 

  18. Kita M et al (1989) Radiotherapy of malignant glioma–prospective randomized clinical study of whole brain vs. local irradiation. Gan No Rinsho 35(11):1289–1294

    PubMed  CAS  Google Scholar 

  19. Phillips C et al (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68(1):23–26

    Article  PubMed  Google Scholar 

  20. Prados MD et al (2001) Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 49(1):71–77

    PubMed  CAS  Google Scholar 

  21. Deutsch M et al (1989) Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. International Int J Rad Oncol Biol Phys 16(6):1389–1396

    CAS  Google Scholar 

  22. Ludgate CM et al (1988) Superfractionated radiotherapy in grade III, IV intracranial gliomas. Int J Rad Oncol Biol Phys 15(5):1091–1095

    CAS  Google Scholar 

  23. Shin KH et al (1985) Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer 56(4):758–760

    Article  PubMed  CAS  Google Scholar 

  24. Fulton DS et al (1984) Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys 10:1709–1712

    PubMed  CAS  Google Scholar 

  25. Shin KH, Muller PJ, Geggie PH (1983) Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer 52(11):2040–2043

    Article  PubMed  CAS  Google Scholar 

  26. Payne DG et al (1982) Malignant astrocytoma: hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 50(11):2301–2306

    Article  PubMed  CAS  Google Scholar 

  27. Stuschke M, Thames HD (1997) Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 37(2):259–267

    PubMed  CAS  Google Scholar 

  28. Kleinberg L et al (1997) Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Rad Oncol Biol Phys 38(1):31–36

    CAS  Google Scholar 

  29. Bauman GS et al (1994) A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Rad Oncol Biol Phys 29(4):835–839

    CAS  Google Scholar 

  30. Sultanem K et al (2004) The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 58(1):247–252

    Article  PubMed  Google Scholar 

  31. Roa W et al (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22(9):1583–1588

    Article  PubMed  CAS  Google Scholar 

  32. Hulshof MC et al (2000) Hypofractionation in glioblastoma multiforme. Radiother Oncol 54(2):143–148

    Article  PubMed  CAS  Google Scholar 

  33. Ford JM et al (1997) A short fractionation radiotherapy treatment for poor prognosis patients with high grade glioma. Clin Oncol (R Coll Radiol) 9(1):20–24

    CAS  Google Scholar 

  34. Hoegler DB, Davey P (1997) A prospective study of short course radiotherapy in elderly patients with malignant glioma. J Neuro-oncol 33(3):201–204

    Article  CAS  Google Scholar 

  35. Slotman BJ et al (1996) Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors. Int J Rad Oncol Biol Phys 34(4):895–898

    CAS  Google Scholar 

  36. Thomas R et al (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33(2):113–116

    Article  PubMed  CAS  Google Scholar 

  37. Glinski B (1993) Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial. J Neuro-oncol 16(2):167–172

    Article  CAS  Google Scholar 

  38. Brada M et al (1999) Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration. Int J Rad Oncol Biol Phys 43(2):287–292

    CAS  Google Scholar 

  39. Werner-Wasik M et al (1996) Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 77(8):1535–1543

    Article  PubMed  CAS  Google Scholar 

  40. Horiot JC et al (1988) European organization for research on treatment of cancer trials using radiotherapy with multiple fractions per day. A 1978–1987 survey. Front Radiat Ther Oncol 22:149–161

    PubMed  CAS  Google Scholar 

  41. Keim H et al (1987) Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiotherapy and Oncology : Radiother Oncol 9(1):21–26

    Article  PubMed  CAS  Google Scholar 

  42. Simpson WJ, Platts ME (1976) Fractionation study in the treatment of glioblastoma multiforme. International Int J Radiat Oncol Biol Phys 1(7–8):639–644

    PubMed  CAS  Google Scholar 

  43. Wen PY et al (1994) Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 73(12):3029–3036

    Article  PubMed  CAS  Google Scholar 

  44. Sneed PK et al (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40(2):287–295

    PubMed  CAS  Google Scholar 

  45. Sneed PK et al (1995) Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 36(5):898–903 discussion 903–904

    Article  PubMed  CAS  Google Scholar 

  46. Chang CN et al (2003) High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes. J Neurooncol 61(1):45–55

    Article  PubMed  Google Scholar 

  47. Koot RW et al (2000) Brachytherapy: results of two different therapy strategies for patients with primary glioblastoma multiforme. Cancer 88(12):2796–2802

    Article  PubMed  CAS  Google Scholar 

  48. Videtic GM et al (2001) Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 51(4):963–968

    PubMed  CAS  Google Scholar 

  49. Lamborn KR, Chang SM, Prados MD (2004) Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6(3):227–235

    Article  PubMed  Google Scholar 

  50. Laperriere NJ et al (1998) Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41(5):1005–1011

    PubMed  CAS  Google Scholar 

  51. Selker RG et al (2002) The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51(2):343–355 discussion 355–357

    Article  PubMed  Google Scholar 

  52. Chang CN et al (2003) High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes. J Neurooncol 61(1):45–55

    Article  PubMed  Google Scholar 

  53. Mayr MT et al (2002) Results of interstitial brachytherapy for malignant brain tumors. Int J Oncol 21(4): 817–823

    PubMed  Google Scholar 

  54. Curran WJ Jr et al (1993) Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyper-fractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11(5):857–862

    PubMed  Google Scholar 

  55. Lustig RA, Scott CB, Curran WJ (2004) Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies? Am J Clin Oncol 27(5):516–521

    Article  PubMed  Google Scholar 

  56. Souhami L et al (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 60(3):853–860

    PubMed  Google Scholar 

  57. Masciopinto JE et al (1995) Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82(4):530–535

    PubMed  CAS  Google Scholar 

  58. Gannett D et al (1995) Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 33(2):461–468

    PubMed  CAS  Google Scholar 

  59. Buatti JM et al (1995) Linac radiosurgery for high-grade gliomas: the University of Florida experience. Int J Radiat Oncol Biol Phys 32(1):205–210

    PubMed  CAS  Google Scholar 

  60. Mehta MP et al (1994) Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30(3):541-549

    PubMed  CAS  Google Scholar 

  61. Kondziolka D et al (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41(4):776–783 discussion 783–785

    Article  PubMed  CAS  Google Scholar 

  62. Larson DA et al (1996) Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 36(5):1045–1053

    PubMed  CAS  Google Scholar 

  63. Sarkaria JN et al (1995) Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32(4): 931–941

    PubMed  CAS  Google Scholar 

  64. Cho KH et al (2004) Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme. Technol Cancer Res Treat 3(1):41–49

    Google Scholar 

  65. Nwokedi EC et al (2002) Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50(1):41–46 discussion 46–47

    Article  PubMed  Google Scholar 

  66. Shrieve DC et al (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90(1):72–77

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We wish to acknowledge Stephen Haines, MD, Jack Rock, MD, and Tom Mikkelson, MD for their review and consultations regarding on this work. The authors also wish to express appreciation to the AANS/CNS Joint Guidelines Committee for their review, comments and suggestions. We also thank Linda Phillips for meeting organization and collection of materials and Emily Feinstein for her assistance in editing the material for publication.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA

    John Buatti

  2. Department of Neurosurgery, University of Iowa College of Medicine, Iowa City, IA, USA

    Timothy C. Ryken

  3. Department of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Mark C. Smith

  4. Department of Radiation Oncology, University of California, San Francisco, CA, USA

    Penny Sneed

  5. Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH, USA

    John H. Suh

  6. Department of Radiation Oncology, University of Wisconsin, Madison, WI, USA

    Minesh Mehta

  7. Department of Neurosurgery, Emory University School of Medicine, 1365B Clifton Rd., NE, Ste. 6200, Atlanta, GA, 30322, USA

    Jeffrey J. Olson

Authors
  1. John Buatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy C. Ryken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark C. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Penny Sneed
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John H. Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Minesh Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeffrey J. Olson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey J. Olson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buatti, J., Ryken, T.C., Smith, M.C. et al. Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol 89, 313–337 (2008). https://doi.org/10.1007/s11060-008-9617-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-008-9617-2

Keywords

Search

Navigation